5-Aminosalicylic acid inhibits inflammatory responses by suppressing JNK and p38 activity in murine macrophages

Immunopharmacol Immunotoxicol. 2017 Feb;39(1):45-53. doi: 10.1080/08923973.2016.1274997.

Abstract

Context: 5-Aminosalicylic acid (5-ASA), as an anti-inflammatory drug, has been extensively used for the treatment of mild to moderate active ulcerative colitis (UC), but the possible mechanisms of action remain unclear.

Objective: To investigate the effects of 5-ASA on the production of inflammatory mediators by murine macrophages stimulated with lipopolysaccharide (LPS), and determine the underlying pharmacological mechanism of action.

Materials and methods: The levels of nitric oxide (NO) and interleukin-6 (IL-6) were measured by Varioskan Flash and IL-6 Enzyme-Linked Immunosorbent Assay sets. Real time quantitative polymerase chain reaction was used to determine the level of induced nitric oxide synthase (iNOS). The effects of 5-ASA on iNOS, the c-Jun N-terminal kinases (JNKs), p38 and nuclear factor (NF)-κB signaling pathways were examined using western blotting.

Results: 5-ASA suppressed the production of NO and IL-6, and also decreased the expression of iNOS in LPS-induced RAW264.7 cells. 5-ASA inhibited the phosphorylation of JNKs and p38, but did not block NF-κB activation at all doses tested.

Discussion and conclusion: The results indicated that the anti-inflammatory effect of 5-ASA was mainly regulated by the inhibition of the JNKs, p38 pathways rather than NF-κB pathway. Further research is required to clarify the detailed mechanism of the action.

Keywords: 5-Aminosalicylic acid; JNK; NO; lipopolysaccharide; p38.

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / pathology
  • Interleukin-6 / immunology
  • MAP Kinase Kinase 4
  • MAP Kinase Signaling System / drug effects*
  • MAP Kinase Signaling System / immunology
  • Macrophages / immunology*
  • Macrophages / pathology
  • Mesalamine / pharmacology*
  • Mice
  • Nitric Oxide / immunology
  • Nitric Oxide Synthase Type II / immunology
  • RAW 264.7 Cells
  • p38 Mitogen-Activated Protein Kinases / immunology*

Substances

  • Interleukin-6
  • interleukin-6, mouse
  • Nitric Oxide
  • Mesalamine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4